Johanna Mercier

Johanna Mercier

Director/Board Member at ARCUS BIOSCIENCES, INC.

Net worth: 16 M $ as of 2026-06-29

56 year
Health Technology
Consumer Services
Health Services

Profile

Ms. Johanna Mercier is a Chief Commercial Officer at Gilead Sciences, Inc. and a Member at World 50, Inc. She is on the Board of Directors at Neurocrine Biosciences, Inc., Leonard D Schaeffer Center For Health Policy & Economics and Robert Wood Johnson University Hospital, Inc. Ms. Mercier was previously employed as a President-US Commercial by Bristol Myers Squibb Co. She received her undergraduate degree from the University of Montréal and an MBA from Concordia University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-07-14 121,234 ( 0.01% ) 15 M $ 2026-06-29
2026-05-26 6,853 ( 0.01% ) 1 M $ 2026-06-29

Johanna Mercier active positions

CompaniesPositionStart
GILEAD SCIENCES, INC. Corporate Officer/Principal 2019-06-30
NEUROCRINE BIOSCIENCES, INC. Director/Board Member 2021-04-14
ARCUS BIOSCIENCES, INC. Director/Board Member 2024-01-28
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -

Former positions of Johanna Mercier

CompaniesPositionEnd
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 2019-05-31
See the detail of Johanna Mercier's experience

Training of Johanna Mercier

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Technology Services

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Johanna Mercier